in Health and Fitness

Novo Nordisk’s ‘Semaglutide’ Shown To Cut Body Weight For The Overweight, Obese

Unprecedented results” for patients with obesity in 68-week trial

1.3k Views

Credit: Johan Wessman

From PharmaTimes.com…..

Novo Nordisk’s glucagon-like peptide-1 (GLP-1) agonist semaglutide significantly cut body weight in a large-scale trial of adults who are overweight or obese.

Read More

Leave a Reply

Loading…

Raphael Warnock Election Group In Hot Water Again, Georgia State AG To Investigate

Six Nations Tournament: Entire Irish Rugby Team Refuses To ‘Take A Knee’ Saying They Don’t Support What BLM Stands For